David A. Siegel Moderna, Inc. Transaction History

Two Sigma Advisers, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $2.67 Million - $3.61 Million	-31,300 Reduced 89.94%	3,500 $372,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.42 Million - $3.63 Million	34,800 New	34,800 $3.46 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $2.83 Million - $3.84 Million	23,900 New	23,900 $2.9 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $1.8 Million - $3.34 Million	-14,225 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $101 Million - $165 Million	-447,800 Reduced 96.92%	14,225 $3.61 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $31.5 Million - $68.7 Million	-141,900 Reduced 23.5%	462,025 $178 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $58 Million - $105 Million	446,100 Added 282.65%	603,925 $142 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $48.4 Million - $82.4 Million	-443,200 Reduced 73.74%	157,825 $20.7 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $32.7 Million - $84.6 Million	497,825 Added 482.39%	601,025 $62.8 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $5.61 Million - $9.79 Million	103,200 New	103,200 $7.3 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $225,492 - $608,000	-7,600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $135,128 - $240,008	7,600 New	7,600 $228,000
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $154,476 - $227,682	-12,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $172,620 - $357,084	12,600 New	12,600 $184,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.